What are Extracellular Vesicles (EVs)? EVs are membrane-enclosed nanoparticles that contain diverse molecular cargo (e.g., RNA, protein) released by cells in the body. EVs can be accessed through liquid biopsies, a minimally invasive alternative to surgical biopsies that can enable easier detection of a broad range of diseases. One of the key advantages of EVs in diagnostics is their ability to reflect (or mirror) the molecular status of cells, including the presence of disease, making them ideal candidates for the development of disease biomarkers. The utilization of EVs as a source of biomarkers in disease detection and monitoring is poised to revolutionize the field of liquid biopsy diagnostics.
At FYR, we are passionate about harnessing the power of a multiomics approach in disease diagnostics. By leveraging a multitude of data sources, including RNA, protein, and DNA, we are able to paint a vivid, comprehensive and accurate picture of both disease and human health. Our focus is on unlocking the full potential of EVs as a key component of this multiomics approach. To fully realize the benefits of this approach, we are actively developing and implementing a range of innovative tools and techniques specifically designed to leverage the full potential of EVs as a unique window into biology.
We fuel new relationships, collaborations, and strategic partnerships involving multiomics target discovery and diagnostic test development. Let’s kindle the next generation of innovation together. To learn more about our innovations in diagnostics and EV research, contact us.